Diagnostics AI
By
Can Personalis and Tempus Leverage AI to Transform Cancer Recurrence Detection for 150,000 Colorectal Patients? Strategic Expansion Deepens MRD Leadership
Key Highlights AI at the Core of Next-Gen Recurrence MonitoringThe expansion of Personalis’ NeXT Personal® MRD test into…
Is Microsoft’s AI Diagnostic Orchestrator the Beginning of the End for Traditional Doctors — With 4X Higher Accuracy Shaking Up Global Healthcare?
Key Highlights Breakthrough in Diagnostic Accuracy with Microsoft’s AIMicrosoft announced its Diagnostic Orchestrator achieved 85.5% accuracy across 304…
NVIDIA and GE HealthCare Join Forces to Accelerate Autonomous Medical Imaging with Physical AI
Key Highlights: GTC, Santa Clara, CA — NVIDIA and GE HealthCare today announced a strategic collaboration to develop…
Is Thermo Fisher’s $10B Q2 Surge the Inflection Point for AI-Powered Biopharma? How Will It Reshape the Life Sciences Landscape?
Key Highlights Financial Resilience and Strategic MarginsThermo Fisher Scientific’s Q2 2025 report showcases its fortress-like financial discipline. With…
Can IGC Pharma’s New AI Models Change Alzheimer’s Diagnosis and Drug Discovery for Millions?
New tools unveiled at AAIC 2025 aim to detect Alzheimer’s earlier and faster, even in low-resource settings Key…
